We continue this trend, but our goal is to elucidate the role of the p53 tumor suppressor in the regulation of one particular participant in the copper metabolism pathways, Atox1, by paying attention to the responses of this protein to typical tumor therapy stimuli, such as cytotoxic drugs and ionizing radiation. This evidence concerns the gene ATOX1 and neoplasm.